Feldan receives $1.2M in third round of financing

Feldan receives $1.2M in third round of financing
March 24
13:21 2015

Members of Anges Québec, the Anges Québec Capital Fund and Fier Succès invested over $1.2M in Feldan, a Quebec company that develops cell therapy products.

With this third round of financing completed, the biotechnology company can now rely on a $675K investment from 15 angels, including Jean-Marc Rousseau and Sylvain Chartier, $475K from the Anges Québec Capital Fund and $75K from Fier Succès.

Feldan is engaged in the production of laboratory reagents essential to activating stem cells likely to restore damaged cells of patients stricken by various pathologies.

Press release.

Related Articles

SIGN UP FOR DAILY DEALS AND NEWS UPDATE

CVCA Events

CVCA on Twitter